Study of RAI1 Gene in Smith-Magenis Syndrome Patients
Author Information
Author(s): Vilboux Thierry, Ciccone Carla, Blancato Jan K., Cox Gerald F., Deshpande Charu, Introne Wendy J., Gahl William A., Smith Ann C. M., Huizing Marjan
Primary Institution: National Human Genome Research Institute, National Institutes of Health
Hypothesis
The study investigates the role of RAI1 gene mutations in patients with Smith-Magenis syndrome who do not have the typical 17p11.2 deletion.
Conclusion
The study found that RAI1 expression is significantly decreased in patients with RAI1 mutations, suggesting its critical role in the syndrome's phenotype.
Supporting Evidence
- RAI1 mRNA expression was significantly decreased in cells of patients with the common 17p11.2 deletion.
- 10 patients with RAI1 variants were identified among the 36 patients studied.
- Two clinical features, ocular abnormalities and object insertion, were significantly correlated with decreased RAI1 expression.
- Patients with de novo RAI1 mutations displayed significantly decreased RAI1 expression compared to controls.
Takeaway
This study looks at a gene called RAI1 in kids who have a condition called Smith-Magenis syndrome, finding that changes in this gene can affect how they grow and behave.
Methodology
The study involved genetic sequencing of the RAI1 gene and analysis of RNA expression levels in lymphoblastoid cells from patients.
Potential Biases
Potential bias in patient selection as only those with specific clinical features were included.
Limitations
The study's sample size is relatively small, and the findings may not be generalizable to all patients with Smith-Magenis syndrome.
Participant Demographics
The cohort was primarily Caucasian, with one Hispanic and one individual of Indian descent.
Statistical Information
P-Value
p<0.05
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website